Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2026 7.646M
June 30, 2026 5.759M
March 31, 2026 5.235M
December 31, 2025 5.825M
September 30, 2025 1.622M
June 30, 2025 1.686M
March 31, 2025 1.438M
December 31, 2024 1.560M
September 30, 2024 0.8424M
June 30, 2024 1.353M
March 31, 2024 0.3896M
December 31, 2023 0.2944M
September 30, 2023 0.2973M
June 30, 2023 0.3015M
March 31, 2023 0.2356M
December 31, 2022 0.2629M
Date Value
September 30, 2022 0.2379M
June 30, 2022 0.2291M
March 31, 2022 0.2412M
December 31, 2021 0.3852M
September 30, 2021 0.4551M
June 30, 2021 0.6526M
March 31, 2021 0.6731M
December 31, 2020 1.046M
September 30, 2020 1.616M
June 30, 2020 1.738M
March 31, 2020 1.447M
December 31, 2019 1.377M
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018 10.23M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 357.70M
Amgen, Inc. 81.70B
Anika Therapeutics, Inc. 52.02M
BioCryst Pharmaceuticals, Inc. 988.45M
Imunon, Inc. 9.386M

Total Liabilities (Quarterly) Related Metrics